Journal Guide

Nature Reviews' clinical content is written by internationally renowned clinical academics and researchers and targeted towards readers in the medical sciences, from postgraduate level upwards. While intended to be read by practicing doctors, researchers and academics within a specialty, we aim to make all our articles accessible to readers working in any medical discipline.In-depth Reviews present authoritative, up-to-date information on a topic, placing it in the context of a field's history and development. Topical discussion and opinions are proffered in Perspectives and News & Views articles, and in the Research Highlights section we filter primary research from a range of specialty and general medical journals.Subjects covered * Aging and dementia * Brain imaging * Epilepsy * Genetics * Headache * Infectious disease * Injury, repair and rehabilitation * Movement disorders * Neural tube defects * Neurodegenerative disease * Neuroimmunology and neuroinflammation * Neurometabolic disorders * Neuromuscular disease * Neurooncology * Neuropsychiatric disorders * Neurosurgery * Public health * Ethics * Pain * Peripheral neuropathies * Sensory systems * Sleep * Spongiform encephalopathies * Stroke * White matter disease (including demyelinating and dysmyelinating disorders).

NeuroMolecular Medicine presents cutting-edge research articles and critical reviews on the molecular and biochemical basis of neurological disorders. Coverage ranges from genetic analyses of human populations to animal and cell culture models of neurological disorders, and includes findings concerning the identification of genetic aberrancies and their pathogenic mechanisms at the molecular and cellular levels. Coverage includes experimental analyses of molecular cascades involved in the development and adult plasticity of the nervous system, in neurological dysfunction, and in neuronal degeneration and repair. NeuroMolecular Medicine encompasses basic research in molecular genetics, signal transduction, plasticity, and cell death. The journal gives special attention to synthetic research and reviews that aim to bridge genetic aberrancies with cellular and molecular mechanisms of neurological pathogenesis.

Basic, translational and clinical research on the following topics as they relate to stress will be covered:

• Molecular substrates and cell signaling
• Genetics and epigenetics
• Stress circuitry
• Structural and physiological plasticity
• Developmental Aspects
• Laboratory models of stress
• Neuroinflammation and pathology
• Memory and Cognition
• Motivational Processes
• Fear and Anxiety
• Stress-related neuropsychiatric disorders (including depression, PTSD, substance abuse)
• Neuropsychopharmacology

The journal provides a source for communication on the latest findings in all areas of contemporary neurochemistry and other fields of relevance (including molecular biology, biochemistry, physiology, neuroimmunology, pharmacology) in order to expand understanding of the functions of nervous system. It presents papers on functional neurochemistry, nervous system receptors, neurotransmitters, myelin, chromaffin granules and other components of the nervous system, as well as neurophysiological and clinical aspects, behavioral reactions, etc. Relevant topics include structure and function of the nervous system proteins, neuropeptides, nucleic acids, nucleotides, lipids, and other biologically active components. The journal presents theoretical material suggesting novel principles and approaches to neurochemical problems, presentations of new hypotheses and significant findings, discussions, chronicles of congresses, meetings, and conferences with short presentations of the most sensational and timely reports, in

Neurochemical Research is devoted to the rapid publication of studies that use neurochemical methodology in research on nervous system structure and function. The journal publishes original reports of experimental and clinical research results, perceptive reviews of significant problem areas in the neurosciences, brief comments of a methodological or interpretive nature, and research summaries conducted by leading scientists whose works are not readily available in English.

Neurochemistry International is devoted to the rapid publication of outstanding original articles and timely reviews in neurochemistry. Manuscripts on a broad range of topics will be considered, including molecular and cellular neurochemistry, neuropharmacology and genetic aspects of CNS function, neuroimmunology, metabolism as well as the neurochemistry of neurological and psychiatric disorders of the CNS.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Neuroendocrinology publishes original research covering all aspects from basic to clinical neuroendocrinology. The journal explores the complex bidirectional interactions between the nervous systems and the endocrine systems in both physiological and pathological conditions.

The journal reports on the latest contributions elucidating roles of the peptidic and steroidal hormones and other substances in the control of reproduction, development, sex/gender, degeneration, energy balance, stress responses, inflammation, rhythms, cognition, behavior, tumors and aging. In addition to basic or clinical research, published articles appeal to cutting edge omics approaches and imaging methods to address the molecular functioning and neuroanatomy of neuroendocrine systems in this rapidly expanding field.

Neuroendocrinology seeks scientific excellence. The journal regularly publishes special/focus issues of topical interest and contemporary review articles by renowned experts to address hot topics in current research.

The aim of Neuropeptides is the rapid publication of original research and review articles, dealing with the structure, distribution, actions and functions of peptides in the central and peripheral nervous systems. The explosion of research activity in this field has led to the identification of numerous naturally occurring endogenous peptides which act as neurotransmitters, neuromodulators, or trophic factors, to mediate nervous system functions. Increasing numbers of non-peptide ligands of neuropeptide receptors have been developed, which act as agonists or antagonists in peptidergic systems.The journal provides a unique opportunity of integrating the many disciplines involved in all neuropeptide research. The journal publishes articles on all aspects of the neuropeptide field, with particular emphasis on gene regulation of peptide expression, peptide receptor subtypes, transgenic and knockout mice with mutations in genes for neuropeptides and peptide receptors, neuroanatomy, physiology, behaviour, neurotrophic factors, preclinical drug evaluation, clinical studies, and clinical trials.Original papers predominate. Manuscripts may be of any length, but must be complete studies; preliminary communications are not accepted. Review articles and hypothesis papers are welcomed, and will be evaluated in the same way as experimental papers. Authors intending to submit a review are advised to communicate their intentions to the Editor, to avoid possible duplication.

Neuropharmacology publishes high quality, original research and review articles within the discipline of neuroscience, especially articles with a neuropharmacological component. However, papers within any area of neuroscience will be considered. The journal does not usually accept clinical research, although preclinical neuropharmacological studies in humans may be considered. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Only in exceptional circumstances will natural products be considered, and then only if the preparation is well defined by scientific means. Neuropharmacology publishes articles of any length (original research and reviews).Neuropharmacology also publishes succinct topical reviews on subjects within its remit. These reviews (of between 3000 and 5000 words) are commissioned by the Editorial Team or arise after correspondence with potential authors. Unsolicited reviews will be considered, but authors are encouraged to contact the Editor-in-Chief ahead of time of their intention to submit a review and to indicate clearly how the review differs from, and adds to, recent published reviews on related topics. On the basis of the case made by authors, potential overlap with planned Neuropharmacology content, and discussions with the Editorial Team, the Editor-in-Chief will provide authors with a decision regarding their proposed review as quickly as possible.The scope of the journal is broad. It covers many disciplines and spans molecules (e.g., molecular biology, biochemistry) through systems (e.g., neurophysiology) to behaviour (e.g. cognition, psychopharmacology). The journal covers all aspects of neuroscience with an emphasis on neurotransmitters and their receptors, ion channels, signalling, psychcopharmacology and animal models of disease, such as investigations on the neurobiology of cognition, depression, schizophrenia, anxiety, epilepsy, ischaemia, neuroprotection, neurodegeneration, drugs of abuse and pain.The journal publishes occasional Special Issues (and will consider publishing Supplements). Each year Elsevier/Neuropharmacology organise a satellite symposium to the Meeting of the Society for Neuroscience. The journal publishes a Special Issue to accompany each meeting. Please see http://www.neuropharmacology-conference.elsevier.com/ for details of this year's meeting and accompanying Special Issue.US National Institutes of Health (NIH) voluntary posting ("Public Access") policyNeuropharmacology and Elsevier facilitate the author's response to the NIH Public Access Policy. For more details please see the Guide for authors

Neurotoxicology and Teratology provides a forum for publishing new information regarding the effects of chemical and physical agents on the developing, adult or aging nervous system. In this context, the fields of neurotoxicology and teratology include studies of agent-induced alterations of nervous system function, with a focus on behavioral outcomes and their underlying physiological and neurochemical mechanisms. The Journal publishes original, peer-reviewed Research Reports of experimental, clinical, and epidemiological studies that address the neurotoxicity and/or functional teratology of pesticides, solvents, heavy metals, nanomaterials, organometals, industrial compounds, mixtures, drugs of abuse, pharmaceuticals, animal and plant toxins, atmospheric reaction products, and physical agents such as radiation and noise. These reports include traditional mammalian neurotoxicology experiments, human studies, studies using non-mammalian animal models, and mechanistic studies in vivo or in vitro. Special Issues, Reviews, Commentaries, Meeting Reports, and Symposium Papers provide timely updates on areas that have reached a critical point of synthesis, on aspects of a scientific field undergoing rapid change, or on areas that present special methodological or interpretive problems. Theoretical Articles address concepts and potential mechanisms underlying actions of agents of interest in the nervous system. The Journal also publishes Brief Communications that concisely describe a new method, technique, apparatus, or experimental result.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Ophthalmic Research'' features original papers, reviews and short communications reporting basic and clinical experimental studies. Authors from throughout the world cover morphologic, physical, physiologic, pharmacological, biochemical and molecular biological aspects of ophthalmology and experimental eye research. Articles on methodological problems are included as well. The results of new experimental research are also interpreted in light of their importance to the clinical work of the eye specialist. This journal provides a record of international research for both researchers and clinicians in ophthalmology.

PLoS Computational Biology features works of exceptional significance that further our understanding of living systems at all scales—from molecules and cells, to patient populations and ecosystems—through the application of computational methods. Readers include life and computational scientists, who can take the important findings presented here to the next level of discovery.Research articles that primarily describe new methods and offer only limited biological insight will be considered only in those exceptional instances in which the method is expected to significantly impact the field of computational biology, typically making substantial breakthroughs in areas of demonstrated importance. Research articles modeling aspects of biological systems should demonstrate both scientific novelty and profound new biological insights. Research articles describing improved or routine methods, models, software, and databases will not be considered by PLoS Computational Biology, and may be more appropriate for PLoS ONE.Generally, reliability and significance of biological discovery are validated and enriched by experimental studies. Experimental validation is not required for publication, however, nor does experimental validation of a modest biological discovery render a manuscript suitable for PLoS Computational Biology.For all submissions, authors must clearly provide detail, data, and software to ensure readers' ability to reproduce the models, methods, and results.Authors unsure of whether their work is within the scope of the journal should submit a presubmission inquiry.

Peptides is an international journal presenting original contributions on the chemistry, biochemistry, neurochemistry, endocrinology, gastroenterology, physiology, and pharmacology of peptides, as well as their neurological, psychological and behavioral effects. Peptides emphasizes all aspects of peptide research and covers investigations of these proteins in plants, insects, lower vertebrates, animals and clinical studies in humans.Please bookmark this URL: http://www.elsevier.com/locate/peptidesUS National Institutes of Health (NIH) voluntary posting ("Public Access") policy:Peptides and Elsevier facilitate the author's response to the NIH Public Access Policy. For more details please see the Guide for authors.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Prion is the first international peer-reviewed journal to focus exclusively on protein folding and misfolding, protein assembly disorders, protein-based and structural inheritance. The goal is to foster communication and rapid exchange of information through timely publication of important results using traditional as well as electronic formats. The overriding criteria for publication in Prion are originality, scientific merit and general interest.Prion is a quarterly publication. Accepted manuscripts will be made available on the website immediately.

This journal presents a forum for the publication of papers in the rapidly growing area of Purinergic Signalling (through purines and pyrimidines), with its exceptionally wide spectrum of signalling functions in health and disease. Coverage includes original articles, reviews, hot topics and controversies, and meeting reports. There is both short-term purinergic signalling in transmission and secretion and long-term (trophic) signalling in controlling cell proliferation, differentiation, motility and death in development and regeneration and there is increasing interest in the roles of purines and pyrimidines in pathophysiological conditions and their therapeutic potential in disease. At the molecular level, rapid progress has been made in understanding the mechanisms of nucleotide and nucleoside release, their extracellular metabolism, the intracellular signalling cascades elicited by receptor activation and the cross-talk with other essential signalling pathways.Details on the Submission and Publicationd

RSC Chemical Biology is a gold open access journal dedicated to publishing and disseminating exceptional, breakthrough research and high-quality reviews at the interface of chemistry and biology. We welcome contributions from across the breadth of the chemical biology field. This includes Sensing and Imaging, Bioorthogonal chemistry, Biosynthesis, Biomimetics and Bioengineering, Synthetic biology, Directed evolution, Drugs development and mechanism of action, Glycoscience, Natural products, Nucleic acids, Peptides, Phenotypic screening, Proteins (including protein-protein interactions, modifications, structure and function) We are particularly interested in reports on the application of chemical tools to probe, explore and visualize biological systems and processes to provide insights into molecular mechanisms in health and disease. We also encourage translational research that bridges chemistry and chemical biology to medicine.

Regulatory Peptides provides a scientific medium for reviews, viewpoints, research articles and correspondence (in the form of Letters to the Editor) on the physiology/pathophysiology of peptides and proteins of the gut and endocrine- and nervous systems which regulate cell, tissue or organ function. Articles may be based on either basic or clinical science observations obtained in any of the fields of biochemistry, physiology, pathology, pharmacology, neuroscience, psychology and clinical medicine. Articles should strive to provide mechanistic explanations rather than merely be observational reports. Communications on comparative physiology research will be considered if novel mechanistic or translational aspects are included.Note: Reviews and Viewpoints may be submitted by invitation only, but authors may send proposals to the Editor-in-Chief for consideration.

SYNAPSE publishes articles concerned with all aspects of synaptic structure and function. This includes neurotransmitters, neuropeptides, neuromodulators, receptors, gap junctions, metabolism, plasticity, circuitry, mathematical modeling, ion channels, patch recording, single unit recording, development, behavior, pathology, toxicology, etc.

Translational Neurodegeneration is a open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. It aims to provide an forum for international researchers and practitioners to discuss all areas of neurodegenerative diseases including epidemiology, etiology, pathogenesis, diagnosis, management and prevention, as well as their molecular, biochemical and physiological aspects. Our goal is to close the gap between basic research and clinical work in neurodegeneration.Topics of interest include but are not limited to the following areas of neurodegenerative diseases: Epidemiology and pathogenesisResearch into diagnosis and preventionResearch into the diease pathogenesis Development of new drugs and cell therapyDrug delivery RehabilitationBy offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration aims to create a novel interface between the fields of basic medical research, translational research and clinical research into Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease, and other related neurodegenerative diseases. It offers the opportunity for basis scientists, clinicians and physician-scientists to publish their research and clinical trials in a journal which is applicable to their specific field.